| DESCRIPTION |
Carbapenems are a class of beta-lactam antibiotics with a broad spectrum
patient's current or prior history of CRE based on laboratory reporting
and the time frames that are entered to search for the patient's status.
The result must occur as a CRE bacterial etiology and any result
contained in a "Free-Text" section will not allow incorporation of the
CRE into the MDRO Program Tools software. Refer to the "VistA Lab
Enhancements (VLE) - Microbiology User Guide" for instructions to
configure the MDRO Tools Lab Parameter Setup to properly run the CRE
Report.
of antibacterial activity. These agents have the broadest antibacterial
spectrum compared to other beta-lactam classes. They are active against
both Gram positive and Gram negative bacteria, and can be used to treat
nosocomial and mixed bacterial infections. Resistance to carbapenems is of
importance because it limits therapeutic options.
NOTE: The purpose of adding carbapenem-resistant enterobacteriaceae (CRE)
etiologies to the MDRO Tools Lab Parameter Setup is to identify a
|
